| abstract |
FIELD: chemistry. n SUBSTANCE: present invention relates to novel cannabidiol quinone derivatives of formula (I) or to their pharmaceutically acceptable salts n n n n where R represents a carbon atom of a linear or branched group represented by an alkoxycarbonyl group; or wherein R represents a nitrogen atom of a linear or branched group represented by an alkylamino or benzylamine group used to treat diseases mediated by PPRAg, as well as to the composition containing the compounds of the invention. n EFFECT: new cannabidiol quinone derivatives are proposed. n 8 cl, 15 dwg, 10 ex |